Compound Prescription definition

Compound Prescription means a prescription that meets the following criteria: (a) two or more solid, semi-solid or liquid ingredients, at least one of which is a Covered Drug; (b) that are weighed or measured then prepared according to the prescriber’s order and pharmacist’s art.
Sample 1Sample 2Sample 3
Compound Prescription means a prescription where two or more medications are mixed together, and in which, at minimum, one medication must be a Federal Legend Drug. The end product must not be available in an equivalent commercial form. A prescription will not be considered a compound prescription if it is reconstituted or if, to the active ingredient, only water, alcohol or sodium chloride solutions are added.
Sample 1Sample 2Sample 3
Compound Prescription means medication that consists of two or more solid, semisolid, or liquid ingredients that are weighed, measured, prepared, or mixed by, or under, the direction of a pharmacist according to a prescription order. These formulations are generally not readily available or approved by the Food and Drug Administration.
Sample 1

Examples of Compound Prescription in a sentence

  • Compound Prescription Drugs in which all ingredients are covered under the plan.

  • Compound Prescription DrugsThe plan will not cover compound prescription drugs that cost less than $300 and include an ingredient not approved by theU.S. Food and Drug Administration.

  • Any commercially available product with a unique assigned NDC requiring reconstitution or mixing according to the FDA approved package insert prior to dispensing will not be considered a Compound Prescription by this Program.

  • TRICARE Reimbursement Criteria and PCCA’s Reported AWPs Are Both Material to the Payment of Compound Prescription Claims.

  • Compound Prescription: A prescription where two or more medications are mixed together.

  • The Project upgraded and strengthened the technology infrastructure institutions which have led to lower costs for Turkish firms, closer links between firms and public R&D institutions and greater attention to IPRs. Also, the Project raised the awareness of the importance of R&D and showed firms how to design and manage R&D projects, disciplined their R&D teams, and put them in close contact with academics in the relevant disciplines.

  • Prior Authorization for Certain Compound Prescription Drugs Effective as of March 1, 2015, prior authorization is required for compound medications available under the Plan.

  • The RIEs, which represent the NCERT in their respective regions of the country, are yet to gain academic autonomy to be able to try out new experiments on education.

  • Any commercially available product with a unique assigned NDC requiring reconstitution or mixing according to the FDA-approved package insert prior to dispensing will not be considered a Compound Prescription by this Program.

  • Compound Prescription Drugs in which all ingredients are covered under the plan.5. Prescription Drugs for the treatment of impotence and/or sexual dysfunction are limited to organic (non-psychological) causes.PRESCRIPTION DRUG SERVICES AND SUPPLIES THAT ARE NOT COVEREDIn addition to the items listed in this Evidence of Coverage under PRUDENT BUYER PLAN EXCLUSIONS AND LIMITATIONS and GENERAL EXCLUSIONS AND LIMITATIONS, Prescription Drug benefits are not provided for or in connection with the following:1.


More Definitions of Compound Prescription

Compound Prescription means a prescription where two or more medications are mixed together. One of these drugs must be a Federal legend drug. The end product must not be available in an equivalent commercial form. A prescription will not be considered a compound prescription if it is reconstituted or if only water, alcohol, or sodium chloride solutions are added to the active ingredient. Compound drugs are reimbursed based off rates specified in the pharmacy provider agreement executed between the pharmacy and CVS/Caremark.
Sample 1Sample 2Sample 3
Compound Prescription means a Prescription Drug which would require the dispensing pharmacist to produce an extemporaneously produced mixture containing at least one Federal Legend drug, the end product of which is not available in an equivalent commercial form. For purposes of this Schedule, a prescription will not be considered a Compound Drug if it is reconstituted or if the only ingredient added to the prescription is water, alcohol, a sodium chloride solution or other common dilatants.
Sample 1
Compound Prescription means a prescription drug which requires the dispensing pharmacist to produce an extemporaneously produced mixture containing at least one federal legend drug, the end product of which is not available in an equivalent commercial form.
Sample 1
Compound Prescription means a prescription consisting of two or more ingredients, at least one of which is a prescription drug, and which is prepared by the pharmacist specifically for the Member according to the prescriber’s directions. For the avoidance of doubt, the addition of only water and/or flavoring does not result in a Compound Prescription.
Sample 1Sample 2
Compound Prescription means a medication that consists of two or more solid, semisolid, or liquid ingredients that are weighed, measured, prepared, or mixed by, or under, the direction of a pharmacist according to a prescription order. These formulations are generally not readily available or approved by the Food and Drug Administration (FDA).
Sample 1Sample 2

Related to Compound Prescription

  • Formulation means the combination of various ingredients designed to render the product useful and effective for the purpose claimed, or the form of pesticide as purchased by users;

  • Compound means the taking of two or more ingredients and fabricating them into a single

  • Prescription device means an instrument, apparatus, implement, machine,

  • Licensed Compound means (a) 3,4-Diaminopyridine, the chemical structure of which is set forth on Exhibit B-2; and (b) any derivatives, isomers, metabolites, prodrugs, acid forms, base forms, salt forms, or modified versions of such compound in (a).

  • Diagnostic Product means In Vitro Diagnostics, In Vivo Diagnostic Agents and any product used for Diagnosis.

  • medicinal product means any substance or combination of substances presented for treating or preventing disease in human beings or animals and any substance or combination of substances which may be administered to human beings or animals with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions in humans or in animals;

  • Biological Samples means any physical samples obtained from Study Participants in accordance with the Protocol for the purposes of the Study.

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Active Pharmaceutical Ingredient or “API” shall mean one or more of the following active pharmaceutical ingredients: tenofovir alafenamide (“TAF”), tenofovir disoproxil fumarate (“TDF”), elvitegravir (“EVG”), and cobicistat (“COBI”).

  • Pharmaceutical Product shall have the meaning ascribed to such term in Section 3.1(hh).

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.

  • Compounds means a small molecule HMT inhibitor.

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Product means any deliverable under the Contract, which may include commodities, services, technology or software.

  • Biological product means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein other than a chemically synthesized polypeptide, or analogous product, or arsphenamine or any derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human beings.

  • Licensed Product means any method, process, composition, product, service, or component part thereof that would, but for the granting of the rights set forth in this Agreement, infringe a Valid Claim contained in the Licensed Patents.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • ingredient means any substance, including a food additive used in the manufacture or preparation of food and present in the final product, possibly in a modified form;

  • Dose is a generic term that means absorbed dose, dose equivalent, effective dose equivalent, committed dose equivalent, committed effective dose equivalent, total organ dose equivalent, or total effective dose equivalent. For purposes of these regulations, "radiation dose" is an equivalent term.

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Drug Product means a specific drug in dosage form from a known source of manufacture, whether

  • Companion Diagnostic means a device which is essential for the safe and effective use of a corresponding medicinal product to:

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Phase III Clinical Trial means a large, controlled or uncontrolled Clinical Study that would satisfy the requirements of 21 CFR 312.21(c), intended to gather the additional information about effectiveness and safety that is needed to evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling.